Predilife S.A. (EPA:ALPRE)
France · Delayed Price · Currency is EUR 1.240
+0.120 (10.71%)
Sep 4, 2026, 12:25 PM CET
Predilife Revenue
Predilife had revenue of 392.77K EUR in the half year ending June 30, 2025, with 138.30% growth. This brings the company's revenue in the last twelve months to 728.08K, up 134.21% year-over-year. In the year 2024, Predilife had annual revenue of 493.20K with 55.20% growth.
Revenue (ttm)
728.08K
Revenue Growth
+134.21%
P/S Ratio
5.29
Revenue / Employee
39.80K
Employees
21
Market Cap
4.42M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 493.20K | 175.41K | 55.20% |
| Dec 31, 2023 | 317.79K | 29.19K | 10.11% |
| Dec 31, 2022 | 288.60K | 146.52K | 103.12% |
| Dec 31, 2021 | 142.08K | 90.51K | 175.51% |
| Dec 31, 2020 | 51.57K | 28.70K | 125.48% |
| Dec 31, 2019 | 22.87K | 5.99K | 35.45% |
| Dec 31, 2018 | 16.89K | -20.53K | -54.87% |
| Dec 31, 2017 | 37.42K | 37.41K | 467,600.00% |
| Dec 31, 2016 | 8.00 | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.92B |
| EssilorLuxottica Société anonyme | 29.29B |
| Ipsen | 4.29B |
| Sartorius Stedim Biotech | 3.01B |
| Spineway | 12.96M |
| Bluelinea Société Anonyme | 11.12M |
| Oncodesign Precision Medicine Société anonyme | 1.81M |
| Plant Advanced Technologies | 1.65M |